newsfilter
← Latest News
PR Newswire·

Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and...